Cariprazine Completed Phase 3 Trials for Schizophrenic Disorders Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01412060A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia